Beutel Goodman & Co Ltd. Buys New Shares in eMagin Corporation $EMA

Beutel Goodman & Co Ltd. purchased a new position in eMagin Corporation (NYSE:EMA) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 256,268 shares of the company’s stock, valued at approximately $12,277,000.

Other large investors have also recently made changes to their positions in the company. Parallel Advisors LLC grew its position in shares of eMagin by 130.9% in the first quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock valued at $26,000 after purchasing an additional 288 shares in the last quarter. Gold Investment Management Ltd. purchased a new position in eMagin during the third quarter worth approximately $27,000. Mather Group LLC. purchased a new position in eMagin during the third quarter worth approximately $38,000. EverSource Wealth Advisors LLC lifted its position in eMagin by 54.4% during the first quarter. EverSource Wealth Advisors LLC now owns 1,093 shares of the company’s stock worth $57,000 after buying an additional 385 shares in the last quarter. Finally, Tompkins Financial Corp purchased a new position in eMagin during the third quarter worth approximately $120,000.

eMagin Price Performance

EMA opened at $50.55 on Tuesday. The stock’s 50-day moving average price is $48.60 and its 200 day moving average price is $51.18. eMagin Corporation has a 12-month low of $45.27 and a 12-month high of $55.49.

eMagin Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 30th will be paid a dividend of C$0.74 per share. This represents a $2.96 dividend on an annualized basis and a yield of 5.9%. This is a boost from eMagin’s previous quarterly dividend of C$0.73. The ex-dividend date is Friday, October 30th.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on EMA shares. Weiss Ratings upgraded shares of eMagin from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, October 23rd. Barclays decreased their target price on shares of eMagin from $53.00 to $50.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Finally, Wall Street Zen cut shares of eMagin from a “sell” rating to a “strong sell” rating in a research note on Saturday, October 31st. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, eMagin presently has a consensus rating of “Hold” and a consensus price target of $50.00.

eMagin Profile